cox 189 has been researched along with ethinyl estradiol-norgestrel combination in 1 studies
| Studies (cox 189) | Trials (cox 189) | Recent Studies (post-2010) (cox 189) | Studies (ethinyl estradiol-norgestrel combination) | Trials (ethinyl estradiol-norgestrel combination) | Recent Studies (post-2010) (ethinyl estradiol-norgestrel combination) |
|---|---|---|---|---|---|
| 163 | 49 | 47 | 482 | 145 | 94 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caldwell, J; Elder, C; Kalbag, J; Leese, P; Milosavljev, S; Rordorf, C; Scott, G; Wang, Y | 1 |
1 trial(s) available for cox 189 and ethinyl estradiol-norgestrel combination
| Article | Year |
|---|---|
Concomitant administration of lumiracoxib and a triphasic oral contraceptive does not affect contraceptive activity or pharmacokinetic profile.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Cross-Over Studies; Cyclooxygenase 2; Diclofenac; Double-Blind Method; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Isoenzymes; Membrane Proteins; Organic Chemicals; Progesterone; Prostaglandin-Endoperoxide Synthases; Sex Hormone-Binding Globulin | 2004 |